News Focus
News Focus
Replies to #54420 on Biotech Values
icon url

DewDiligence

11/06/07 7:44 PM

#54421 RE: justrpaul #54420

>I suspect Vertex could submit a little after 48 weeks from the last enrollee [in the phase-3 control arms]<

If you're referring to phase-3, I concur. That’s why I said 48 weeks rather than 72 weeks. Regards, Dew